Regeneron, Sanofi asthma drug data fails to excite investors Ruby Khatun Khatun13 Sept 2017 1:42 PM ISTPARIS: Shares of Regeneron Inc and Sanofi SA slid on Monday after late-stage trial data for their asthma drug, dupilumab, fell short of investor...
New AstraZeneca, Amgen drug looks strong rival in severe asthma Ruby Khatun Khatun11 Sept 2017 10:27 AM ISTLONDON: A new kind of injectable biotech treatment for severe asthma from AstraZeneca and Amgen promises to help a much broader range of patients than...
Dr Reddys launches antidepressant, muscle relaxant tablets in US Ruby Khatun Khatun7 Sept 2017 11:19 AM ISTNew Delhi: Dr. Reddy's Laboratories on Wednesday said it has launched Bupropion Hydrochloride extended-release tablets used in treating a major...
Google bets on European biotech drugs, backs new fund Ruby Khatun Khatun19 Jun 2017 9:26 AM ISTLONDON: Google is betting on the potential of European biotech companies to deliver life-changing drugs by investing alongside Swiss company Novartis...
Exclusive: Pfizer weighs sale or spin off of consumer health unit - sources supriya kashyap kashyap10 Nov 2016 1:32 PM ISTn" style="transform: translate3d(0px, 0px, 0px);"U.S. drugmaker Pfizer Inc is evaluating a potential sale or spin-off of its consumer health division...
GlaxoSmithKline invests $360 million in post Brexit UK manufacturing savita thakur thakur28 July 2016 12:44 PM ISTLondon : Drugmaker GlaxoSmithKline revealed plans to invest £275 million into three of its British manufacturing sites, shrugging off Brexit...
